TerminatedPHASE1, PHASE2NCT01149434
Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers
Studying Neuroendocrine tumor of the colon
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Utah
- Principal Investigator
- Sunil Sharma, MDHuntsman Cancer Institute
- Intervention
- JI-101(drug)
- Enrollment
- 19 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2012
Study locations (1)
- Huntsman Cancer Institute, Salt Lake City, Utah, United States
Collaborators
Jubilant Innovation Ltd.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01149434 on ClinicalTrials.gov